Skip to main content
Search
Main navigation
Videos
Podcasts
Articles
Quizzes
Resources
Editorial Board
Psych Congress Coverage
Search
Main navigation
Videos
Podcasts
Articles
Quizzes
Resources
Editorial Board
Psych Congress Coverage
Welcome to Clinical Topics in Depression
This website is intended for healthcare professionals in the United States.
Yes, I am a US healthcare professional
No, I am not a US healthcare professional
Pipeline Update: Drugs in Phase 3 Development for Major Depressive Disorder (MDD)
Pipeline Update: Drugs in Phase 3 Development for Major Depressive Disorder (MDD)
Current
Question 1
Pipeline Update: Drugs in Phase 3 Development for Major Depressive Disorder (MDD)
Question 2
Complete
Which drug targets have agents directed at them in phase 3 development?
a. Orexin
b. Glutamate/gamma-aminobutyric acid (GABA)
c. Oxidative stress
d. Metabolic dysfunction
